Aspira Women's Health Inc... (AWH)
| Bid | n/a |
| Market Cap | 2.89M |
| Revenue (ttm) | 9.18M |
| Net Income (ttm) | -13.09M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -0.09 |
| Forward PE | -0.32 |
| Analyst | Buy |
| Ask | n/a |
| Volume | 2,869,147 |
| Avg. Volume (20D) | 4,780,901 |
| Open | 0.09 |
| Previous Close | 0.08 |
| Day's Range | 0.08 - 0.09 |
| 52-Week Range | 0.02 - 3.45 |
| Beta | 2.01 |
Analyst Forecast
According to 0 analyst ratings, the average rating for AWH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · accessnewswire.com
Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"SHELTON, CT / ACCESS Newswire / April 17, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco...
2 months ago · accessnewswire.com
Aspira Women's Health Inc. Announces Receipt of Delisting Notification from NasdaqSHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco...
2 months ago · accessnewswire.com
Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase AgreementNew Directors Bring Extensive Commercial Healthcare Relationships to Expand Business Development Opportunities. AUSTIN, TX / ACCESS Newswire / April 8, 2025 / Aspira Women's Health Inc. ("Aspira" o...
3 months ago · accessnewswire.com
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health AwardThe Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical...
3 months ago · accessnewswire.com
Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial ResultsRecord 2024 OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq:AWH), a bio-...
3 months ago · accessnewswire.com
Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible NotesAUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecol...
4 months ago · accessnewswire.com
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of DirectorsAUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyne...